Stock Scorecard
Stock Summary for Tandem Diabetes Care Inc (TNDM) - $22.07 as of 12/22/2025 6:20:03 PM EST
Total Score
7 out of 30
Safety Score
38 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TNDM
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TNDM
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TNDM
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TNDM
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TNDM (38 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TNDM
Financial Details for TNDM
Company Overview |
|
|---|---|
| Ticker | TNDM |
| Company Name | Tandem Diabetes Care Inc |
| Country | USA |
| Description | Tandem Diabetes Care, Inc. is a prominent medical device manufacturer located in San Diego, California, specializing in cutting-edge insulin delivery technologies for individuals with insulin-dependent diabetes. The company's flagship t:slim X2 insulin delivery system integrates state-of-the-art features such as automated insulin delivery and continuous glucose monitoring, establishing Tandem as a leader in the diabetes management sector. With a strong commitment to innovation and a robust research and development framework, Tandem is well-positioned to capitalize on the growing demand for personalized and intelligent healthcare solutions, aiming to enhance patient outcomes in an evolving market. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/25/2026 |
Stock Price History |
|
| Last Day Price | 22.07 |
| Price 4 Years Ago | 150.52 |
| Last Day Price Updated | 12/22/2025 6:20:03 PM EST |
| Last Day Volume | 1,900,149 |
| Average Daily Volume | 2,258,040 |
| 52-Week High | 38.28 |
| 52-Week Low | 9.98 |
| Last Price to 52 Week Low | 121.14% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 41.90 |
| Sector PE | 53.39 |
| 5-Year Average PE | 13.84 |
| Free Cash Flow Ratio | 16.23 |
| Industry Free Cash Flow Ratio | 28.74 |
| Sector Free Cash Flow Ratio | 33.77 |
| Current Ratio Most Recent Quarter | 2.44 |
| Total Cash Per Share | 1.36 |
| Book Value Per Share Most Recent Quarter | 1.96 |
| Price to Book Ratio | 11.25 |
| Industry Price to Book Ratio | 4.40 |
| Sector Price to Book Ratio | 49.15 |
| Price to Sales Ratio Twelve Trailing Months | 1.49 |
| Industry Price to Sales Ratio Twelve Trailing Months | 7.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 14.97 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 67,802,000 |
| Market Capitalization | 1,496,390,140 |
| Institutional Ownership | 115.62% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -37.00% |
| Annual Earnings Growth | 56.86% |
| Reported EPS 12 Trailing Months | -3.03 |
| Reported EPS Past Year | -1.76 |
| Reported EPS Prior Year | -1.90 |
| Net Income Twelve Trailing Months | -203,366,000 |
| Net Income Past Year | -96,025,000 |
| Net Income Prior Year | -222,611,000 |
| Quarterly Revenue Growth YOY | 2.20% |
| 5-Year Revenue Growth | 21.01% |
| Operating Margin Twelve Trailing Months | -8.05% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 91,947,000 |
| Total Cash Past Year | 69,234,000 |
| Total Cash Prior Year | 58,868,000 |
| Net Cash Position Most Recent Quarter | -217,643,000 |
| Net Cash Position Past Year | -239,032,000 |
| Long Term Debt Past Year | 308,266,000 |
| Long Term Debt Prior Year | 285,035,000 |
| Total Debt Most Recent Quarter | 309,590,000 |
| Equity to Debt Ratio Past Year | 0.46 |
| Equity to Debt Ratio Most Recent Quarter | 0.30 |
| Total Stockholder Equity Past Year | 263,098,000 |
| Total Stockholder Equity Prior Year | 313,632,000 |
| Total Stockholder Equity Most Recent Quarter | 132,965,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -25,125,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.37 |
| Free Cash Flow Past Year | 4,994,000 |
| Free Cash Flow Prior Year | -58,614,000 |
Options |
|
| Put/Call Ratio | 0.16 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.39 |
| MACD Signal | 1.33 |
| 20-Day Bollinger Lower Band | 7.93 |
| 20-Day Bollinger Middle Band | 15.48 |
| 20-Day Bollinger Upper Band | 23.04 |
| Beta | 1.69 |
| RSI | 61.97 |
| 50-Day SMA | 20.07 |
| 150-Day SMA | 28.68 |
| 200-Day SMA | 37.85 |
System |
|
| Modified | 12/20/2025 10:43:24 AM EST |